{"id":{"repo_id":"greece","oai_identifier":"oai:10442/51183"},"canonical_url":"https://search.ndltd.org/etd/greece/oai:10442/51183","repository":{"repo_id":"greece","name":"Greek National Archive of PhD Theses","base_url":"https://phdtheses.ekt.gr/eadd_oai/request"},"display":{"title":"Διαχείριση και θεραπεία ασθενών με λοιμώξεις στο άνω άκρο: μελέτη της εκλεκτικής ανοσιακής απάντησης με ιντερλευκίνες 1 και 17","abstract":"Laboratory diagnosis of upper limb infections is of major importance. The present laboratory findings have a great sensitivity but a low specificity. IL-1β, IL-17A and IL-17F are cytokines that play a significant role in inflammation and infectious diseases. The purpose of this prospective cohort study is to evaluate the levels of IL-1β, IL-17A and IL-17F and their relationship with clinical severity and the other laboratory findings in patients with upper extremity infections. Patients with signs or symptoms of upper extremity infection were eligible for the study. Age, sex, height, weight, and body mass index (BMI) were recorded from each patient in the study. Smoking habit and comorbidities, along with site and type of infection were also recorded. The Visual Analogue Scale (VAS) was used to evaluate the pain of the affected limb and the Quick DASH Score was used to assess the severity of upper limb injury. ESR and CRP were measured along with the number and type of WBC. Serum levels of IL-1β, IL-17A and IL-17F, were measured by immunoenzymatic ELISA method. Swab cultures and Gram stain were performed in all patients. Fifty one patients (38 men – 13 women) with a mean age 51.7 years old were enrolled in the study. Serum level of IL-1β was < 0.000 in 49 patients. Accordingly, serum level of IL-17F was < 0.000 in 50 patients. On the contrary, 27.4% of the patients had elevated levels of IL-17A. Serum level of IL-17A is not correlated with sex, age, BMI, comorbidities, fever, VAS score, WBC, CRP, ESR and IL-17F. A trend for association was noticed between IL-17A and DASH score (rho = 0.264, p = 0.061) and a strong association was observed between IL-17A and IL-1β (rho = 0.380, p = 0.006). No correlation was detected between serum levels of IL-17A and type of isolated bacteria, Gram stain, site and type of infection (p > 0.05). After controlling the impact of sex, age and BMI, a trend for association was observed between IL-17A and VAS score (p = 0.077) and a marginal significant association was observed between IL-17A and DASH score (p = 0.050). In conclusion, serum levels of IL-1β and IL-17F are not influenced by upper limb infections. IL-17A may be increased in some infections of upper extremities, accordingly to the severity of infection, indicating that IL-17A may be a dynamic indicator for these patients. Further studies, of high quality, are required in order to fully elucidate the role of IL-17A in upper limb infections.","abstract_html":"Laboratory diagnosis of upper limb infections is of major importance. The present laboratory findings have a great sensitivity but a low specificity. IL-1β, IL-17A and IL-17F are cytokines that play a significant role in inflammation and infectious diseases. The purpose of this prospective cohort study is to evaluate the levels of IL-1β, IL-17A and IL-17F and their relationship with clinical severity and the other laboratory findings in patients with upper extremity infections. Patients with signs or symptoms of upper extremity infection were eligible for the study. Age, sex, height, weight, and body mass index (BMI) were recorded from each patient in the study. Smoking habit and comorbidities, along with site and type of infection were also recorded. The Visual Analogue Scale (VAS) was used to evaluate the pain of the affected limb and the Quick DASH Score was used to assess the severity of upper limb injury. ESR and CRP were measured along with the number and type of WBC. Serum levels of IL-1β, IL-17A and IL-17F, were measured by immunoenzymatic ELISA method. Swab cultures and Gram stain were performed in all patients. Fifty one patients (38 men – 13 women) with a mean age 51.7 years old were enrolled in the study. Serum level of IL-1β was &lt; 0.000 in 49 patients. Accordingly, serum level of IL-17F was &lt; 0.000 in 50 patients. On the contrary, 27.4% of the patients had elevated levels of IL-17A. Serum level of IL-17A is not correlated with sex, age, BMI, comorbidities, fever, VAS score, WBC, CRP, ESR and IL-17F. A trend for association was noticed between IL-17A and DASH score (rho = 0.264, p = 0.061) and a strong association was observed between IL-17A and IL-1β (rho = 0.380, p = 0.006). No correlation was detected between serum levels of IL-17A and type of isolated bacteria, Gram stain, site and type of infection (p &gt; 0.05). After controlling the impact of sex, age and BMI, a trend for association was observed between IL-17A and VAS score (p = 0.077) and a marginal significant association was observed between IL-17A and DASH score (p = 0.050). In conclusion, serum levels of IL-1β and IL-17F are not influenced by upper limb infections. IL-17A may be increased in some infections of upper extremities, accordingly to the severity of infection, indicating that IL-17A may be a dynamic indicator for these patients. Further studies, of high quality, are required in order to fully elucidate the role of IL-17A in upper limb infections.","abstract_has_math":false,"creators":["Syngouna, Sophia","Συγγούνα, Σοφία"],"institution":"National and Kapodistrian University of Athens","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022","date_published":"2022","updated_at":"2026-11-18T21:42:32Z","subjects":["Κυτοκίνες","Λοιμώξεις","Άνω άκρο","IL - 1β (Ιντερλευκίνη - 1β)","Ιντερλευκίνη-17Α","Ιντερλευκίνη-17F","Cytokines","Infections","Upper limb","Interleukin- 1b","Interleukin-17A","Interleukin-17F","Κλινική Ιατρική","Ιατρική και Επιστήμες Υγείας","Ορθοπεδική και Αθλιατρική","Clinical Medicine","Medical and Health Sciences","Orthopedics and Sports Medicine"],"languages":["gre"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/51183"],"render_values":[{"text":"10.12681/eadd/51183","href":"https://doi.org/10.12681/eadd/51183","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/10442/hedi/51183","outbound_label":"Handle","outbound_source":"dc:identifier","record_url":"http://hdl.handle.net/10442/hedi/51183","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://phdtheses.ekt.gr/eadd_oai/request?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3A10442%2F51183","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Syngouna, Sophia","Συγγούνα, Σοφία"]},{"key":"dc:creator.fathername","label":"Dc Creator Fathername","values":["Apostolos"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022"]},{"key":"dc:publisher","label":"Institution","values":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"]},{"key":"dc:type","label":"Dc Type","values":["PhD Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Κυτοκίνες","Λοιμώξεις","Άνω άκρο","IL - 1β (Ιντερλευκίνη - 1β)","Ιντερλευκίνη-17Α","Ιντερλευκίνη-17F","Cytokines","Infections","Upper limb","Interleukin- 1b","Interleukin-17A","Interleukin-17F","Κλινική Ιατρική","Ιατρική και Επιστήμες Υγείας","Ορθοπεδική και Αθλιατρική","Clinical Medicine","Medical and Health Sciences","Orthopedics and Sports Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["gre"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/51183","http://hdl.handle.net/10442/hedi/51183"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Laboratory diagnosis of upper limb infections is of major importance. The present laboratory findings have a great sensitivity but a low specificity. IL-1β, IL-17A and IL-17F are cytokines that play a significant role in inflammation and infectious diseases. The purpose of this prospective cohort study is to evaluate the levels of IL-1β, IL-17A and IL-17F and their relationship with clinical severity and the other laboratory findings in patients with upper extremity infections. Patients with signs or symptoms of upper extremity infection were eligible for the study. Age, sex, height, weight, and body mass index (BMI) were recorded from each patient in the study. Smoking habit and comorbidities, along with site and type of infection were also recorded. The Visual Analogue Scale (VAS) was used to evaluate the pain of the affected limb and the Quick DASH Score was used to assess the severity of upper limb injury. ESR and CRP were measured along with the number and type of WBC. Serum levels of IL-1β, IL-17A and IL-17F, were measured by immunoenzymatic ELISA method. Swab cultures and Gram stain were performed in all patients. Fifty one patients (38 men – 13 women) with a mean age 51.7 years old were enrolled in the study. Serum level of IL-1β was < 0.000 in 49 patients. Accordingly, serum level of IL-17F was < 0.000 in 50 patients. On the contrary, 27.4% of the patients had elevated levels of IL-17A. Serum level of IL-17A is not correlated with sex, age, BMI, comorbidities, fever, VAS score, WBC, CRP, ESR and IL-17F. A trend for association was noticed between IL-17A and DASH score (rho = 0.264, p = 0.061) and a strong association was observed between IL-17A and IL-1β (rho = 0.380, p = 0.006). No correlation was detected between serum levels of IL-17A and type of isolated bacteria, Gram stain, site and type of infection (p > 0.05). After controlling the impact of sex, age and BMI, a trend for association was observed between IL-17A and VAS score (p = 0.077) and a marginal significant association was observed between IL-17A and DASH score (p = 0.050). In conclusion, serum levels of IL-1β and IL-17F are not influenced by upper limb infections. IL-17A may be increased in some infections of upper extremities, accordingly to the severity of infection, indicating that IL-17A may be a dynamic indicator for these patients. Further studies, of high quality, are required in order to fully elucidate the role of IL-17A in upper limb infections.","Η διαχείριση και η θεραπεία ασθενών με λοιμώξεις άνω άκρο έχει μεγάλη σημασία. Οι συνήθεις εργαστηριακοί δείκτες έχουνμεγάλη ευαισθησία, αλλά χαμηλή ευαισθησία. Οι IL-1β, IL-17A and IL-17F είναι κυτοκίνες με σημαίνοντα ρόλο στην διαδικασία της φλεγμονής και των λοιμώξεων. Σκοπός αυτής της προοπτικής μελέτης κοορτής είναι η αξιολόγηση των επιπέδων ΙL-1β, IL-17A and IL-17F και της συσχέτισης τους με την κλινική βαρύτητα και άλλα εργαστηριακά ευρήματα ασθενών με λοιμώξεις άνω άκρου. Στην μελέτη συμπεριλαμβάνονται ασθενείς με σημεία και συμπτώματα λοιμώξεων στο άνω άκρο. Ηλικία, φύλο, ύψος, βάρος και δείκτης μάζας σώματος (ΒΜΧ) καταγράφονται για κλώθε ασθενή της μελέτης. Καταγράφονται ακόμα το κάπνισμα και οι συννοσηρότητες καθώς και η ακριβής θέση και ο τύπος της λοίμωξης. Για την αξιολόγηση του πόνου χρησιμοποιήθηκε η αναλογική κλίμακα του πόνου (VAS) και το Quick DASH Score για την αξιολόγηση της λειτουργικής βαρύτητας του άνω άκρου. Κατεγράφησαν ακόμα οι ΤΚΕ, CRP και ο αριθμός των λευκών αιμοσφαιρίων. Πενήντα ένας ασθενείς(38 άνδρες-13 γυναίκες) με μέσο όρο ηλικίας 51.7 έτη συμπεριλήφθησαν στην μελέτη. Τα επίπεδα της IL-1β στον ορό ήταν < 0.000 σε 49 ασθενείς. Αντίστοιχα, της IL-17F < 0.000 σε 50 ασθενέις. Αντιθέτως, το 27.4% ασθενών έιχαν αυξημένα επίπεδα IL-17A. Η IL-17A δεν είχε συσχέτιση με το φύλο, την ηλικία, το ΒΜΙ, τις συννοσηρότητες, τον πυρετό, το VAS score, τα WBC, CRP, ΤΚΕ και την IL-17F. Παρατηρήθηκε μια τάση συσχέτισης μεταξύ της IL-17A και του DASH score (rho = 0.264, p = 0.061) και ισχυρή συσχέτιση μεταξύ της IL-17A και της IL-1β (rho = 0.380, p = 0.006). Δεν παρατηρήθηκε συσχέτιση μεταξύ των επιπέδων της IL-17A και των τύπων των απομομωμένων βακτηρίων, την Gram ευαισησία, το μέρος και τον τύπο της λοίμωξης (p > 0.05). Μετά τον έλεγχοτου φύλου, της ηλικίας και του ΒΜΙ, μια τάση συσχέτισης παρατηρήθηκε μεταξύ της IL-17A και του VAS score (p = 0.077) και μια οριακά σημαντική συσχέτιση μεταξύ IL-17A και DASH score (p = 0.050)."]},{"key":"dc:title","label":"Title","values":["Διαχείριση και θεραπεία ασθενών με λοιμώξεις στο άνω άκρο: μελέτη της εκλεκτικής ανοσιακής απάντησης με ιντερλευκίνες 1 και 17","Management and treatment of patients with upper limb infections: study of the selective immune response with IL-1 & IL-17","Gestion et traitement de patients avec infection du membre supérieur: etude de la réponse selective immunitaire avec IL-1 & IL-17"]}]}],"canonical_facts":{"dc:creator":["Syngouna, Sophia","Συγγούνα, Σοφία"],"dc:creator.fathername":["Apostolos"],"dc:date":["2022"],"dc:description":["Laboratory diagnosis of upper limb infections is of major importance. The present laboratory findings have a great sensitivity but a low specificity. IL-1β, IL-17A and IL-17F are cytokines that play a significant role in inflammation and infectious diseases. The purpose of this prospective cohort study is to evaluate the levels of IL-1β, IL-17A and IL-17F and their relationship with clinical severity and the other laboratory findings in patients with upper extremity infections. Patients with signs or symptoms of upper extremity infection were eligible for the study. Age, sex, height, weight, and body mass index (BMI) were recorded from each patient in the study. Smoking habit and comorbidities, along with site and type of infection were also recorded. The Visual Analogue Scale (VAS) was used to evaluate the pain of the affected limb and the Quick DASH Score was used to assess the severity of upper limb injury. ESR and CRP were measured along with the number and type of WBC. Serum levels of IL-1β, IL-17A and IL-17F, were measured by immunoenzymatic ELISA method. Swab cultures and Gram stain were performed in all patients. Fifty one patients (38 men – 13 women) with a mean age 51.7 years old were enrolled in the study. Serum level of IL-1β was < 0.000 in 49 patients. Accordingly, serum level of IL-17F was < 0.000 in 50 patients. On the contrary, 27.4% of the patients had elevated levels of IL-17A. Serum level of IL-17A is not correlated with sex, age, BMI, comorbidities, fever, VAS score, WBC, CRP, ESR and IL-17F. A trend for association was noticed between IL-17A and DASH score (rho = 0.264, p = 0.061) and a strong association was observed between IL-17A and IL-1β (rho = 0.380, p = 0.006). No correlation was detected between serum levels of IL-17A and type of isolated bacteria, Gram stain, site and type of infection (p > 0.05). After controlling the impact of sex, age and BMI, a trend for association was observed between IL-17A and VAS score (p = 0.077) and a marginal significant association was observed between IL-17A and DASH score (p = 0.050). In conclusion, serum levels of IL-1β and IL-17F are not influenced by upper limb infections. IL-17A may be increased in some infections of upper extremities, accordingly to the severity of infection, indicating that IL-17A may be a dynamic indicator for these patients. Further studies, of high quality, are required in order to fully elucidate the role of IL-17A in upper limb infections.","Η διαχείριση και η θεραπεία ασθενών με λοιμώξεις άνω άκρο έχει μεγάλη σημασία. Οι συνήθεις εργαστηριακοί δείκτες έχουνμεγάλη ευαισθησία, αλλά χαμηλή ευαισθησία. Οι IL-1β, IL-17A and IL-17F είναι κυτοκίνες με σημαίνοντα ρόλο στην διαδικασία της φλεγμονής και των λοιμώξεων. Σκοπός αυτής της προοπτικής μελέτης κοορτής είναι η αξιολόγηση των επιπέδων ΙL-1β, IL-17A and IL-17F και της συσχέτισης τους με την κλινική βαρύτητα και άλλα εργαστηριακά ευρήματα ασθενών με λοιμώξεις άνω άκρου. Στην μελέτη συμπεριλαμβάνονται ασθενείς με σημεία και συμπτώματα λοιμώξεων στο άνω άκρο. Ηλικία, φύλο, ύψος, βάρος και δείκτης μάζας σώματος (ΒΜΧ) καταγράφονται για κλώθε ασθενή της μελέτης. Καταγράφονται ακόμα το κάπνισμα και οι συννοσηρότητες καθώς και η ακριβής θέση και ο τύπος της λοίμωξης. Για την αξιολόγηση του πόνου χρησιμοποιήθηκε η αναλογική κλίμακα του πόνου (VAS) και το Quick DASH Score για την αξιολόγηση της λειτουργικής βαρύτητας του άνω άκρου. Κατεγράφησαν ακόμα οι ΤΚΕ, CRP και ο αριθμός των λευκών αιμοσφαιρίων. Πενήντα ένας ασθενείς(38 άνδρες-13 γυναίκες) με μέσο όρο ηλικίας 51.7 έτη συμπεριλήφθησαν στην μελέτη. Τα επίπεδα της IL-1β στον ορό ήταν < 0.000 σε 49 ασθενείς. Αντίστοιχα, της IL-17F < 0.000 σε 50 ασθενέις. Αντιθέτως, το 27.4% ασθενών έιχαν αυξημένα επίπεδα IL-17A. Η IL-17A δεν είχε συσχέτιση με το φύλο, την ηλικία, το ΒΜΙ, τις συννοσηρότητες, τον πυρετό, το VAS score, τα WBC, CRP, ΤΚΕ και την IL-17F. Παρατηρήθηκε μια τάση συσχέτισης μεταξύ της IL-17A και του DASH score (rho = 0.264, p = 0.061) και ισχυρή συσχέτιση μεταξύ της IL-17A και της IL-1β (rho = 0.380, p = 0.006). Δεν παρατηρήθηκε συσχέτιση μεταξύ των επιπέδων της IL-17A και των τύπων των απομομωμένων βακτηρίων, την Gram ευαισησία, το μέρος και τον τύπο της λοίμωξης (p > 0.05). Μετά τον έλεγχοτου φύλου, της ηλικίας και του ΒΜΙ, μια τάση συσχέτισης παρατηρήθηκε μεταξύ της IL-17A και του VAS score (p = 0.077) και μια οριακά σημαντική συσχέτιση μεταξύ IL-17A και DASH score (p = 0.050)."],"dc:identifier":["10.12681/eadd/51183","http://hdl.handle.net/10442/hedi/51183"],"dc:language":["gre"],"dc:publisher":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"],"dc:subject":["Κυτοκίνες","Λοιμώξεις","Άνω άκρο","IL - 1β (Ιντερλευκίνη - 1β)","Ιντερλευκίνη-17Α","Ιντερλευκίνη-17F","Cytokines","Infections","Upper limb","Interleukin- 1b","Interleukin-17A","Interleukin-17F","Κλινική Ιατρική","Ιατρική και Επιστήμες Υγείας","Ορθοπεδική και Αθλιατρική","Clinical Medicine","Medical and Health Sciences","Orthopedics and Sports Medicine"],"dc:title":["Διαχείριση και θεραπεία ασθενών με λοιμώξεις στο άνω άκρο: μελέτη της εκλεκτικής ανοσιακής απάντησης με ιντερλευκίνες 1 και 17","Management and treatment of patients with upper limb infections: study of the selective immune response with IL-1 & IL-17","Gestion et traitement de patients avec infection du membre supérieur: etude de la réponse selective immunitaire avec IL-1 & IL-17"],"dc:type":["PhD Thesis"]},"updated_at":"2026-11-18T21:42:32Z"}